KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Opko Health (OPK) Return on Sales (2016 - 2025)

Opko Health (OPK) has disclosed Return on Sales for 16 consecutive years, with 0.31% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Return on Sales fell 47.0% year-over-year to 0.31%, compared with a TTM value of 0.4% through Dec 2025, down 33.0%, and an annual FY2025 reading of 0.4%, down 34.0% over the prior year.
  • Return on Sales was 0.31% for Q4 2025 at Opko Health, down from 0.14% in the prior quarter.
  • Across five years, Return on Sales topped out at 28.79% in Q3 2021 and bottomed at 7.29% in Q1 2023.
  • Average Return on Sales over 5 years is 0.95%, with a median of 0.16% recorded in 2022.
  • The sharpest move saw Return on Sales surged 2874bps in 2021, then tumbled -2927bps in 2022.
  • Year by year, Return on Sales stood at 0.18% in 2021, then skyrocketed by 207bps to 0.2% in 2022, then plummeted by -181bps to 0.16% in 2023, then skyrocketed by 199bps to 0.16% in 2024, then tumbled by -299bps to 0.31% in 2025.
  • Business Quant data shows Return on Sales for OPK at 0.31% in Q4 2025, 0.14% in Q3 2025, and 0.95% in Q2 2025.